Studies have shown yerba mate can increase GLP-1 secretion and promote satiety
The KwikPen became public knowledge at the Mounjaro FDA approval in 2022
The pharmaceutical industry is developing newer and potentially cheaper or more effective molecules that target GLP-1 and associated pathways (for example, the so-called dual- and triple-agonists tirzepatide, retatutride and orfoglipon) 257,258
Patients with high BMI, difficulty controlling appetite, type 2 diabetes or prediabetes, and those who want a clinically proven GLP-1 option with established long-term safety data
Perhaps we have more of a need to tackle the increasing lack of understanding around nutrition and what one should be buying / eating to prevent and reduce chronic diseases that continue to drive up the cost of health care and reduce work force productivity for so many industries
When this quiets down, semaglutide is working on your hypothalamic hunger circuits